Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer
Abstract
Purpose: Pancreatic adenocarcinoma is a highly aggressive cancer, currently treated with limited success and dismal outcomes. New diagnostic and treatment strategies offer the potential to reduce cancer mortality. Developing highly specific noninvasive imaging probes for pancreatic cancer is essential to improving diagnostic accuracy and monitoring therapeutic intervention.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 31, 2016
- Source ID
- 10.1158/1078-0432.ccr-15-2054
Entities
People
- Bai Liu
- Charles P. Theuer
- Christopher G. England
- Haiming Luo
- Hing C. Wong
- Reinier Hernandez
- Robert J. Nickles
- Sixiang Shi
- Stephen A. Graves
- Weibo Cai
Organizations
- American Cancer Society
- National Institutes of Health
- National Science Foundation
- United States Department of Defense
- University of Wisconsin–Madison